Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
941.6 USD | -0.93% | +0.98% | +61.53% |
07-16 | Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly | MT |
07-16 | Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B | |
+2.41% | 126B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Tranche Update on Eli Lilly and Company's Equity Buyback Plan announced on October 3, 2013.